Irisin expression and FNDC5 (rs3480) gene polymorphism in type 2 diabetic patients with and without CAD

被引:2
作者
Foad, Amera Morad [1 ]
Hafez, Alshimaa [1 ]
Youssef, Wael [2 ]
Ahmed, Ahmed Elsharawy [3 ]
Altaher, Ali Mohamad [3 ]
机构
[1] Sohag Univ, Fac Med, Dept Med Biochem, Sohag, Egypt
[2] Sohag Univ, Fac Med, Dept Clin Pathol, Sohag, Egypt
[3] Sohag Univ, Fac Med, Dept Internal Med, Div Cardiol, Sohag, Egypt
关键词
Irisin; coronary artery disease; diabetes mellitus type 2; single nucleotide polymorphism; coronary angiography; IMPROVES ENDOTHELIAL FUNCTION; CORONARY-ARTERY-DISEASE; INSULIN-RESISTANCE; ASSOCIATION; GLUCOSE; ATHEROSCLEROSIS; SEVERITY; MYOKINE; FAT;
D O I
10.1080/13813455.2023.2173785
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BackgroundIrisin was found to correlate with coronary artery disease (CAD) in diabetic patients. This study investigated the association of irisin and FNDC5 (SNP rs3480) with the presence and severity of CAD in T2DM.MethodsThis cross-sectional study included 100 patients with T2DM divided into two groups, DM group (n = 50), including patients without CAD and CAD group (n = 50), including those confirmed to have CAD by coronary angiography. Irisin was measured. SNP rs3480 genotyping of FNDC5 was done.ResultsIrisin levels were significantly lower in the CAD group (p < 0.001). The CAD group had significantly higher HbA1c and lower HDL (p < 0.001). Patients with controlled DM had significantly higher irisin levels (p < 0.001). single nucleotide polymorphism (SNP) rs3480 was not associated with irisin levels, and the FNDC5 rs3480 AA reference allele was significantly associated with significant CAD.ConclusionIrisin appears to be protective against developing CAD in diabetic patients. Irisin level was an independent predictor of significant CAD in diabetic patients combined with the FNDC5 rs3480 genotype.
引用
收藏
页码:523 / 528
页数:6
相关论文
共 46 条
  • [1] Coronary artery disease and diabetes mellitus
    Al-Nozha, Mansour M.
    Ismail, Hussein M.
    Al Nozha, Omar M.
    [J]. JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES, 2016, 11 (04): : 330 - 338
  • [2] Irisin - a myth rather than an exercise-inducible myokine
    Albrecht, Elke
    Norheim, Frode
    Thiede, Bernd
    Holen, Torgeir
    Ohashi, Tomoo
    Schering, Lisa
    Lee, Sindre
    Brenmoehl, Julia
    Thomas, Selina
    Drevon, Christian A.
    Erickson, Harold P.
    Maak, Steffen
    [J]. SCIENTIFIC REPORTS, 2015, 5
  • [4] Circulating irisin levels are lower in patients with either stable coronary artery disease (CAD) or myocardial infarction (MI) versus healthy controls, whereas follistatin and activin A levels are higher and can discriminate MI from CAD with similar to CK-MB accuracy
    Anastasilakis, Athanasios D.
    Koulaxis, Dimitrios
    Kefala, Nikoleta
    Polyzos, Stergios A.
    Upadhyay, Jagriti
    Pagkalidou, Eirini
    Economou, Fotios
    Anastasilakis, Chrysostomos D.
    Mantzoros, Christos S.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2017, 73 : 1 - 8
  • [5] Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events
    Aronis, K. N.
    Moreno, M.
    Polyzos, S. A.
    Moreno-Navarrete, J. M.
    Ricart, W.
    Delgado, E.
    de la Hera, J.
    Sahin-Efe, A.
    Chamberland, J. P.
    Berman, R.
    Spiro, A., III
    Vokonas, P.
    Fernandez-Real, J. M.
    Mantzoros, C. S.
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2015, 39 (01) : 156 - 161
  • [6] A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues
    Aydin, Suleyman
    Kuloglu, Tuncay
    Aydin, Suna
    Kalayci, Mehmet
    Yilmaz, Musa
    Cakmak, Tolga
    Albayrak, Serdal
    Gungor, Sami
    Colakoglu, Neriman
    Ozercan, Ibrahim Hanifi
    [J]. PEPTIDES, 2014, 61 : 130 - 136
  • [7] IRISIN AND CHEMERIN LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Balaban, Y. Akgul
    Yilmaz, N.
    Kalayci, M.
    Unal, M.
    Turhan, T.
    [J]. ACTA ENDOCRINOLOGICA-BUCHAREST, 2019, 15 (04) : 442 - 446
  • [8] Adipose tissue: an endocrine organ playing a role in metabolic regulation
    Booth, Andrea
    Magnuson, Aaron
    Fouts, Josephine
    Foster, Michelle T.
    [J]. HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2016, 26 (01) : 25 - 42
  • [9] A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
    Bostroem, Pontus
    Wu, Jun
    Jedrychowski, Mark P.
    Korde, Anisha
    Ye, Li
    Lo, James C.
    Rasbach, Kyle A.
    Bostroem, Elisabeth Almer
    Choi, Jang Hyun
    Long, Jonathan Z.
    Kajimura, Shingo
    Zingaretti, Maria Cristina
    Vind, Birgitte F.
    Tu, Hua
    Cinti, Saverio
    Hojlund, Kurt
    Gygi, Steven P.
    Spiegelman, Bruce M.
    [J]. NATURE, 2012, 481 (7382) : 463 - U72
  • [10] From white to brown fat through the PGC-1α-dependent myokine irisin: implications for diabetes and obesity
    Castillo-Quan, Jorge Ivan
    [J]. DISEASE MODELS & MECHANISMS, 2012, 5 (03) : 293 - 295